RULES FOR SUBMISSION
All abstracts must be submitted and presented in English and be of a quality suitable for publication.
Only abstracts of authors who have paid their registration fees by Friday, September 19, 2012 will be scheduled for presentation and included in the program.
The author is expected to attend the meeting and present the poster.
If an abstract was previously submitted to a different meeting it may still be submitted to ASRA 2012.
GUIDELINES FOR SUBMISSION
Before you begin, please prepare the following information:
Presenting Author's Contact Details
- Full postal address
- Email address
- Daytime and evening phone number
Author and Co-Authors' Details
- Full first and family name(s)
- Affiliation details: department, institution / hospital, city, state (if relevant), country
Limited to 25 words in Sentence case
Limited to 500 words
(Please Note: word count is affected when graphs/tables/images are added)
Abstracts must be submitted with the following sections:
- Material and methods
There also should be mention of any funding from grants or by any manufacturer or third-party research funding.
Abstracts must be allocated to a specific topic for the scientific program. Please choose from the following topics:
- Scientific Abstract
- Medically Challenging Case
The maximum number of tables allowed per abstract is 3. Each table should be smaller than 10 rows x 10 columns. Each row of the table will be counted as 10 words against your 500 word total.
Graphs and Images
For upload max. 2 graphs are allowed. Each graph is counted as 10 words.
The maximum file size of each graph is 500 KB. The maximum pixel size of the graph is 600(w) x 800(h) pixel. You may upload graphs and images in JPG format only.
If your file size or pixel size is too large, you have to resize your graph accordingly.
After uploading the graph you have to place it into the abstract text! It is not mandatory to include a graph into your abstract
The submission form at the link below allows you to store your abstract as a draft in order to make changes. Please note that abstracts must be SUBMITTED before the deadline in order to be sent to review for inclusion in the scientific program.
Please be advised that you will be requested to confirm the following information when you submit your abstract.
- I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
- Submission of the abstract constitutes my consent to publication (e.g. meeting website, program, other promotions, etc.)
- The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content ("Content") provided to ASRA 2012 and Kenes International (Hereafter: “The Organizers"). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
The Abstract Submitter grants the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
- The Organizers reserve the right to remove from any publication an abstract which does not comply with the above.
- I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
IMPORTANT NOTE - ETHICS COMMITTEE APPROVAL
Only work that has received local animal or human ethics committee approval as appropriate will be considered for presentation and publication. A statement indicating ethics committee approval has been granted should be incorporated into the abstract and you will be requested to confirm that approval has been applied for/granted before you submit your abstract. When submitting your abstract, please upload your Ethics Committee Approval as a picture or as text pasted into the Abstract text field.
Abstracts which have not received approval will not be accepted - unless they fit into the special categories below.
ETHICAL COMMITTEE APPROVAL IS REQUIRED FOR THE FOLLOWING SCENARIOS:
1. If there are patients involved in the study
2. Anonymous Retrospective Data Collection – unless local committee authorizes otherwise
3. Audit Study – unless local committee authorizes otherwise
ETHICAL COMMITTEE APPROVAL IS NOT REQUIRED FOR THE FOLLOWING SCENARIOS:
1. Questionnaire survey of medical personnel
2. Case studies – with patient consent
3. Literature reviews
4. Historical research
5. Research performed on artificial model
6. Evaluation performed during pre-operative session – with receipt of informed consent
CONFLICT OF INTEREST DECLARATION
Presentations must be objective and free of commercial bias and any information regarding commercial products or services must be based on scientific methods generally accepted by the medical community. When discussing therapeutic options, speakers are asked to use only generic names. If it is necessary to use a trade name, then those of several companies are to be used. Further, should presentations include discussion of any unlabeled/ investigational use of a commercial product; speakers are required to disclose that information to the audience.
Please choose one option:
- I declare that there are no conflicts of interest or support that may cause bias in my presentation.
- I confirm that I am aware of conflicts of interest in my presentation. I agree to declare this conflict of interest at the beginning of my presentation during the meeting.